Skip to main content
 -
  • About
    • Advertising Policy
    • Aim and Scope
    • Contact Us
    • Editorial Board
    • Editorial Independence
    • Editorial Policies
      • Artificial Intelligence (AI)-Assisted Technology
      • Authorship and Contributorship
      • Complaints and Appeals
      • Corrections and Retractions
      • Data Sharing and Reproducibility
      • Ethical Practices and Expectations
      • Intellectual Property and Copyright
      • Peer Review
    • Editorial Process
    • History
    • Media
    • Mission
    • Open Access
      • Financial: Author Fees and Disclosure of Funding
    • Permissions
    • Post-publication Discussions
    • Writing Prizes for Medical Students
  • The Journal
    • By Author
    • Past Issues
    • BC Doctors
      • Obituaries
      • Interviews
      • Proust for Physicians
      • Physician Spotlight
    • Opinions
      • Back Page
      • BC Stories
      • Blog
      • Editorials
      • Letters to the Editor
      • Premise
      • President's Comment
    • Columns
      • BC Centre for Disease Control
      • Billing Tips
      • Council on Health Promotion
      • College Library
      • Family Practice Services Committee
      • Joint Collaborative Committees
      • News
      • Shared Care Committee
      • Specialist Services Committee
      • WorkSafeBC
    • Articles
      • Clinical Articles
        • Clinical Case Reports
        • Clinical Images
        • Original Research
        • Review Articles
      • MDs To Be
      • Beyond Medicine
      • COVID-19
      • Early Online
  • Classifieds
  • Submit Content
    • Instructions for Authors: Clinical Article
    • Instructions for Authors: Nonclinical Content
    • Theme Issue
    • Letter to the Editor
  • Advertise
    • Place Display Ad
    • Place Classified Ad
    • Shopping cart
  • none
 -

Author profile

S. Ellard, MD, FRCPC,

hide first letter

Young cancer patient looking out window
Clinical Articles / April 2006

New guidelines for treatment of early hormone-positive breast cancer with tamoxifen and aromatase inhibitors

The Breast Tumour Group, a provincial multidisciplinary committee of the British Columbia Cancer Agency (BCCA), has developed new guidelines for the use of tamoxifen and aromatase inhibitors (AIs) in adjuvant therapy... Read More

BCMJ

The BCMJ is a general medical journal that shares knowledge while building connections among BC physicians.

DOBC

 

ISSN 0007‍-‍0556 (Print)
ISSN 2293‍-‍6106 (Online)
Established 1959